These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4707544)

  • 1. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women.
    Grattarola R
    Am J Obstet Gynecol; 1973 Jun; 116(3):423-8. PubMed ID: 4707544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
    Gratterola R
    Cancer Res; 1978 Sep; 38(9):3051-4. PubMed ID: 679211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
    Grattarola R; Secreto G; Recchione C
    Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and 17 beta-oestradiol secretion of the human ovary. I. normal young women, and premenopausal women with endometrial hyperplasia.
    Botella-Llusiá J; Oriol-Bosch A; Sánchez-Garrido F; Tresguerres JA
    Maturitas; 1980 Jan; 2(1):1-5. PubMed ID: 7402082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
    Pelusi G; Moretti B; Martinelli G; Camerini T; Busacchi P; Cavallina R
    Eur J Gynaecol Oncol; 1983; 4(2):131-4. PubMed ID: 6223817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
    Goldzieher JW; Fariss B
    Acta Endocrinol (Copenh); 1967 Mar; 54(3):452-66. PubMed ID: 6071363
    [No Abstract]   [Full Text] [Related]  

  • 11. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
    Labrie F
    J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal correlations between cancer of the breast and atypical hyperplasia of the endometrium in premenopausal women].
    Pozzi V
    Minerva Ginecol; 1979; 31(7-8):569-74. PubMed ID: 481815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of uterine, endometrial and ovarian blood flow by transvaginal color Doppler ultrasound in ovulatory and anovulatory cycles.
    Dogan O; Yildiz A; Temizkan O; Pulatoglu C
    Ginekol Pol; 2016; 87(8):581-4. PubMed ID: 27629133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of risk factors for hyperplasia and cancer of the endometrium.
    Baanders-van Halewyn EA; Blankenstein MA; Thijssen JH; de Ridder CM; de Waard F
    Eur J Cancer Prev; 1996 Apr; 5(2):105-12. PubMed ID: 8736077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
    Giudice LC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Origin, variations and physiological role of steroid hormones during the menstrual cycle].
    Bercovici JP
    Nouv Presse Med; 1973 Jan; 2(2):103-9. PubMed ID: 4685762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
    Parker CR; Mahesh VB
    J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
    Secreto G; Recchione C; Fariselli G; Di Pietro S
    Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
    Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
    J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.